Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Biochem Pharmacol. 2023 Nov;217:115809. doi: 10.1016/j.bcp.2023.115809. Epub 2023 Sep 17.
Biochem Pharmacol. 2023.
PMID: 37717691
Free article.
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma.
Schedel A, Friedrich UA, Morcos MNF, Wagener R, Mehtonen J, Watrin T, Saitta C, Brozou T, Michler P, Walter C, Försti A, Baksi A, Menzel M, Horak P, Paramasivam N, Fazio G, Autry RJ, Fröhling S, Suttorp M, Gertzen C, Gohlke H, Bhatia S, Wadt K, Schmiegelow K, Dugas M, Richter D, Glimm H, Heinäniemi M, Jessberger R, Cazzaniga G, Borkhardt A, Hauer J, Auer F.
Schedel A, et al. Among authors: watrin t.
Int J Mol Sci. 2022 May 5;23(9):5174. doi: 10.3390/ijms23095174.
Int J Mol Sci. 2022.
PMID: 35563565
Free PMC article.
Item in Clipboard
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
Reusing SB, Vallera DA, Manser AR, Watrin T, Bhatia S, Felices M, Miller JS, Uhrberg M, Babor F.
Reusing SB, et al. Among authors: watrin t.
Cancer Immunol Immunother. 2021 Dec;70(12):3709. doi: 10.1007/s00262-021-03040-0.
Cancer Immunol Immunother. 2021.
PMID: 34491408
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite